Skip to main content

Table 12 Text report of reduced cost of Amoxicillin by 50% point

From: Cost-effectiveness analysis of rapid diagnostic test, microscopy and syndromic approach in the diagnosis of malaria in Nigeria: implications for scaling-up deployment of ACT

P1

Strategy

Cost

Incr Cost

Eff

Incr Eff

C/E

Incr C/E (ICER)

0.2

RDT

$301,037

 

99,953

 

$3

 
 

M

$360,833

 

99,938

 

$4

(Ext Dom)

 

PT

$390,737

$89,700

99,662

291

$4

$309

0.3

RDT

$307,995

 

99,951

 

$3

 
 

M

$366,187

 

99,937

 

$4

(Ext Dom)

 

PT

$378,081

$70,086

99,699

253

$4

$278

0.4

RDT

$314,952

 

99,950

 

$3

 
 

PT

$365,426

$50,473

99,735

214

$4

$235

 

M

$371,540

 

99,935

 

$4

(Dominated)

0.5

RDT

$321,910

 

99,948

 

$3

 
 

PT

$352,770

$30,860

99,772

176

$4

$175

 

M

$376,894

 

99,934

 

$4

(Dominated)

0.6

RDT

$328,867

 

99,946

 

$3

 
 

PT

$340,114

£11,247

99,808

138

$3

$81

 

M

$382,247

 

99,933

 

$4

(Dominated)